Structure of the BfArM (PDF, 119KB, File is accessible)

P
President
Prof. Dr. Karl Broich
3704
P11
Media and Public Relations
Research Council
Research Co-ordinator
P13
Ombudsman,
Change and Idea
Management
Dr. Schulte, A.
Pommer, M.
N.N.
3261
Equal Opportunity
Commissioner
Perry-Mertens, R.
5211
Secr. 0228-99-307-3219/ -3204
Telefax: 0228-99-307-5514
P3
Controlling/ E-Processes
PD Dr. Enzmann, H.
Dr. Scheffler, M.
Secr. 3314
VP
3309
P2
European and International Affairs
3689
3816
Vice President
P21
CMDh
Prof. Dr. Julia Stingl
3575
PharmNet.Bund Authorised
Representative
Dr. Menges, K.
Dir. und Prof. 3458
Organisational
Health Care Managment
Personnel Development
Division Z
Division 1
Division 2
Division 3
Administration
Licensing 1
Licensing 2
Licensing 3
Dr. Halfmann, R.
Dr. Horn, M.
Dr. Weise, M.*
3198
Secr. 3568
4310
Secr. 3333
Z11
Human Resources
11
Validation
Füllmann, J.
Dr. Deicke, A.
Z12
Budget
Winterscheid, S.
21
Project
Management
5855
Division 4
Secr. 3532
31
Project
Management
Norta, M.
12
Simplified Procedures I
22
Gastroenterology/Metabolic
Disorders/Radiology
Ludwig-Merseburg, S.
3866
Dr. Dussa, J.
Dr. Meyer, R.
Z13
Organisational Issues,
Knowledge Management,
Library
Meyer, U.
5844
13
Simplified Procedures II
4705
5945
23
Diabetes Mellitus/
Cardiovascular System
Eibenstein, M.A., G.
5660
Dr. Weise, M.
5482
Dr. Diller, M.
4011
32
Antiinfectives/Antiallergics/
Dermatology/ENT
Matz, S.
3355
33
Anaesthesiology/Algesiology/Rheumatology/
Pneumology
Dr. Schriever. J.
3304
Z14
E-Portal,
Document Management
14
Parallel Imports
24
Oncology/Endocrinology
34
Neurology/Psychiatry/
Ophthalmology
N.N.
Dr. Brendler-Schwaab, S.
3526
Dr. Hermes, U.
Dr. Rems, L.
3686
Z16
Special Legal Issues,
Licensing Fees
3188
25
Genetic and Reproductive
Toxicology
Dr. Göben, J.
PD Dr. Röhrdanz, E.
3235
4517
Dr. Naumann-Winter
3466
Division 7
Division 8
Division 9
Federal Opium Agency
Medical Devices
Prof. Dr. Stingl, J.
PD Dr. Sudhop, T.
3570
Secr. 3571
5975
42
Phytotherapeutic and
Traditional Medicinal
Products
Dr. Wiesner, J.*
5980
43
Homoeopathic and
Anthroposophic Medicinal
Products
Dr. von der Heidt, C.*
3361
Dr. Kirchner, C.*
5301
Dr. Paeschke, N.
4360
Secr. 3129
Prof. Dr. Stingl, J. **
3570
52
Research Group
Pharmacoepidemiology
Prof. Dr. Stingl, J.**
Dir.‘in u. Prof.‘in
3570
53
Research group on
clinical safety of
implants
N.N.
4112
Secr. 3311
Dr. Mende, A.*
3360
Dr. Palissa, H.
4043
Dr. Riedel, C.*
4320
72
PRAC and other
Commitees
62
GCP Inspections
Dr. Huber, M.
Schwarz, G.*
3323
63
Scientific Advice,
Expert Panels
Beinlich, P.*
3958
54
Biostatistics and Special
Pharmacokinetics
64
Legal Affairs
PD Dr. Benda, N.
Völkel, H.
3514
4218
73
Post-authorisation Safety
Studies,
Pharmacovigilance
Centres,
Pharmacoepidemiology
Dr. Straßmann, V.
3538
74
ADR-Processing and
Databases, Medication
Safety
4519
Dr. Norwig, J.
3274
Raunitschke, R.
3767
4236
75
Risk Assessment
Procedures,
Pharmacovigilance
Inspections
Dr. Zimmermann, L.
3232
5944
5134
* temporarily charged with the conduct of affairs/
interim performance of the funktions
** temporary in addition to the function as the Head of
Division
5934
Data Protection
Commissioner
Dexel, F.
Claar, B.
4000
4503
3732
81
Control of Legal Trade in
Precursors, Thalidomide
Register
Rohr, A.
5104
91
Project Management and
Scientific Cross-sectional
Issues
Dr. Rämsch-Günther, N.
3997
82
Control of Legal Trade in
Narcotics and Psychotropic
Substances I and Safety
Measures
Dr. Bräutigam, B.
5127
92
Non-active Medical Devices
83
Control of Legal Trade in
Narcotics and Psychotropic
Substances II
Dr. Greve, H.
5108
93
Active Medical Devices and
In-vitro Diagnostics
84
Issues Relating to
Pharmacists and Physicians
Todt, M.*
Dr. Zündorf, J.
3202
Dr. Stößlein, E.
5384
94
Clinical Trials
Dr. Schriever, U.
4137
95
Methods Research
Medical Device Safety
Dr. Lauer, W. *
5355
Dr. Lütkehermölle, W.
3216
Dr. Grüger, Th.
Social Advice
5355
76
Risk Management I
77
Risk Management II
Skiba, D.
Dr. Lauer, W.
Secr. 5325
5984
Dr. Alesik, E.
3660
65
Pharmacopoeia
Dr. Cremer-Schaeffer, P.
3316
Secr. 5102
71
Project
Management
61
Clinical Trials
66
Information Technology
Representative for Disabled
Employees
Mertes-Engel, N.
3816
Pharmacovigilance
Sent, J.
Kaiser, M.
Dr. Scheffler, M.
3762
Division 6
Z17
Internal Services,
Property Matters
Head of the
Staff Advisory Committee
Hammerl, A.
3363
P33
Quality Management
Scientific Services
35
Pharmaceutical
Biotechnology,
Quality Inspections
Dr. Brake, B.
3482
Melhaf, D
P32
Controlling
Research
5692
Youth and Trainees
Council
P31
E-Processes
Division 5
51
Research Group
Pharmcogenomics
41
Project
Management
Stadler, B.*
3133
3393
Dr. Bachmann, P.
4163
P23
Scientific Quality/
Peer review
Dr. Limberg, J.
Secr. 0228-99-307-3576/ -3897
Telefax: 0228-99-307-3217
Licensing 4
Complementary and Traditional
Medicinal Products
Prof. Dr. Knöss, W.
4172
5638
Secr. 5334
5482
Secr. 3422
P22
COMP
Structure of the
Federal Institute for Drugs
and Medical Devices
(BfArM)
Kurt-Georg-Kiesinger-Allee 3
53175 Bonn
Telefon: (0228) 99-307 – 30
Telefax:
(0228) 99-307 – 5207
E-Mail:
[email protected]
Stand: 01.08.2016
5938

Download Report